Figure 1.
Ranolazine effect on Hb1Ac and short-term GV. (a) Patients with Hb1Ac < 7% at baseline and 3 months in the two groups; (b) Patients with TIR > 70% at baseline and 3 months in the two groups. Hb1Ac: haemoglobin 1Ac; TIR: time in range.
Ranolazine effect on Hb1Ac and short-term GV. (a) Patients with Hb1Ac < 7% at baseline and 3 months in the two groups; (b) Patients with TIR > 70% at baseline and 3 months in the two groups. Hb1Ac: haemoglobin 1Ac; TIR: time in range.